| Serial Number | 90571084 |
| Word Mark | BRILMAFY |
| Filing Date | Wednesday, March 10, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, July 10, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 12, 2022 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 10, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Event Date | Event Description |
| Monday, July 10, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, July 10, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, December 7, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, December 5, 2022 | SOU EXTENSION 1 GRANTED |
| Monday, December 5, 2022 | SOU EXTENSION 1 FILED |
| Monday, December 5, 2022 | TEAS EXTENSION RECEIVED |
| Tuesday, June 7, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 12, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 12, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 23, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 8, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, March 8, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, March 8, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, March 8, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, March 8, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, March 4, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, March 4, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 4, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 15, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 15, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 15, 2021 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 14, 2021 | ASSIGNED TO EXAMINER |
| Thursday, June 10, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, March 13, 2021 | NEW APPLICATION ENTERED |